Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

cardiovascular · Mechanism Report

Does a high arachidonic acid-to-EPA ratio make apoB particles more atherogenic?

A high inflammatory tone and a low EPA, high arachidonic acid-to-EPA pattern promote a pro-inflammatory lipid mediator balance and increase LDL oxidation, making apoB particles more atherogenic.

PlausibleJuly 8, 202615 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Higher inflammatory tone and a low EPA, high arachidonic acid-to-EPA pattern promote pro-inflammatory lipid mediator balance and oxidative modification of LDL particles, making apoB particles more atherogenic.

laying out figure…
1 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes how a higher arachidonic acid-to-EPA ratio is associated with more inflammatory lipid signaling and a more pro-oxidant vascular environment. In this framework, reduced EPA relative to arachidonic acid weakens protection against lipid peroxidation, allowing LDL particles to undergo oxidative modification. Those oxidized apoB particles are then described as more atherogenic.

Verified conclusion

The relationship between dietary fatty acids, systemic inflammation, and cardiovascular risk is driven by the molecular balance between omega-6 and omega-3 polyunsaturated fatty acids. Specifically, the ratio of arachidonic acid (AA) to eicosapentaenoic acid (EPA) dictates cellular inflammatory pathways and lipoprotein stability.

Lipid mediator dynamics and inflammatory tone

  • Substrate competition: AA and EPA compete directly for incorporation into cell membranes and downstream metabolism by cyclooxygenase (COX) and lipoxygenase (LOX) enzymes.
  • Eicosanoid shifting: A high AA-to-EPA ratio drives the synthesis of highly potent, pro-inflammatory 2-series eicosanoids (such as prostaglandin E2 and leukotriene B4). In contrast, EPA yields less potent 3-series eicosanoids and acts as a precursor for E-series resolvins.
  • Systemic tone: This membrane ratio serves as a key substrate-level modulator of systemic inflammatory tone; higher AA:EPA ratios directly correlate with elevated inflammatory markers like high-sensitivity C-reactive protein (hs-CRP) in a bidirectional, self-reinforcing loop.

Oxidative modification and atherogenicity

  • Loss of antioxidant protection: EPA incorporates directly into apolipoprotein B (apoB)-containing particles, where it exerts potent antioxidant effects. A low EPA, high AA pattern deprives these particles of competitive protection, shifting the microenvironment toward lipid peroxidation.
  • Foam cell formation: Oxidative modification converts native LDL into oxidized LDL (oxLDL). These modified apoB particles bypass normal receptor-mediated clearance and are instead rapidly engulfed by macrophage scavenger receptors, promoting vascular inflammation, foam cell formation, and plaque progression.

Bottom line

  • A low EPA, high AA pattern creates a pro-inflammatory, pro-oxidant vascular microenvironment that strips apoB-containing particles of antioxidant protection, promoting LDL oxidation and accelerating plaque formation.

References

  1. Omega-3 Fatty Acids and Inflammatory Processes — pmc.ncbi.nlm.nih.gov ↗
  2. Polyunsaturated Fatty Acids: Conversion to Lipid Mediators, Roles in Inflammatory Diseases and Dietary Sources — pmc.ncbi.nlm.nih.gov ↗
  3. Impact of EPA ingestion on COX- and LOX-mediated eicosanoid ... — pmc.ncbi.nlm.nih.gov ↗
  4. The eicosapentaenoic acid:arachidonic acid ratio and its clinical ... — pubmed.ncbi.nlm.nih.gov ↗
  5. Different Fatty Acids Compete with Arachidonic Acid for Binding to ... — pmc.ncbi.nlm.nih.gov ↗
  6. The eicosapentaenoic acid:arachidonic acid ratio and its clinical ... — tandfonline.com ↗
  7. Modeling enzyme competition in eicosanoid metabolism in ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  8. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. — pmc.ncbi.nlm.nih.gov ↗
  9. Relationship of Omega-3 fatty acids DHA and EPA with ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  10. Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents — pmc.ncbi.nlm.nih.gov ↗
  11. Eicosapentaenoic acid limits the more rapid oxidation of lipoprotein ... — academic.oup.com ↗
  12. Eicosapentaenoic acid (EPA) – Anti-inflammatory lipid mediator — biocrates.com ↗
  13. New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease — pmc.ncbi.nlm.nih.gov ↗
  14. Association between the ratio of serum eicosapentaenoic acid to ... — pmc.ncbi.nlm.nih.gov ↗
  15. Eicosapentaenoic acid inhibits glucose-induced membrane ... — sciencedirect.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesAre F2-isoprostanes biomarkers of lipid peroxidation and does oxidized LDL contribute to atherosclerosis?→Plausible10 sourcesDo hs-CRP, Lp-PLA2, and myeloperoxidase reflect different cardiovascular risk signals?→